Home drugs Braftovi (Encorafenib)

Braftovi (Encorafenib)

This page contains brief information about encorafenib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)      Braftovi
FDA Approved            Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Encorafenib is approved to be used with binimetinib to treat:

  • Melanoma that cannot be removed by surgery or has metastasized (spread to other parts of the body). It is used in patients whose disease has a certain mutation in the BRAF gene.

Encorafenib is also being studied in the treatment of other types of cancer.

More About Encorafenib

Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.